4//SEC Filing
Amman Bradford K. 4
Accession 0001493152-22-036726
CIK 0001716166other
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 9:45 PM ET
Size
5.4 KB
Accession
0001493152-22-036726
Insider Transaction Report
Form 4
Amman Bradford K.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-12-23$0.48/sh+200,000$96,000→ 500,001 totalExercise: $0.48Exp: 2027-12-23→ Common Stock (500,001 underlying)
Footnotes (1)
- [F1]200,000 stock options granted on December 23, 2022. One-fifth vests annually on each anniversary date through December 23, 2026.
Documents
Issuer
Vivos Therapeutics, Inc.
CIK 0001716166
Entity typeother
Related Parties
1- filerCIK 0001425339
Filing Metadata
- Form type
- 4
- Filed
- Dec 27, 7:00 PM ET
- Accepted
- Dec 28, 9:45 PM ET
- Size
- 5.4 KB